Results 101 to 110 of about 32,738 (290)

Tonic-Clonic Seizure following Cytoreductive Surgery with Intraperitoneal Oxaliplatin: A Case Report and Review of the Literature

Case Reports in Oncology, 2016
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal (IP) chemotherapy (HIPEC) is believed to improve outcomes in well-selected patients with peritoneal carcinomatosis.
Jessica Sayuri Tsukamoto, Marcos Belotto de Oliveira, Renata D'Alpino Peixoto   +2 more
doaj   +1 more source

Retrospective Study of the Epidemiology, Pathology, and Therapeutic Management in Patients With Mucinous Ovarian Tumors

Technology in Cancer Research & Treatment, 2020
Aim: We sought to determine the epidemiology of mucinous ovarian tumors, the correlation between serum biomarkers and tumor status, and the outcomes of the management in different subtypes of mucinous ovarian tumors in a Chinese surgical cohort. Methods:
Yuanyuan Zhang PhD, Chunmei Li MD, Suiyu Luo MD, Ying Su MD, Xiaoqing Gang MD, Peiyuan Chu MD, JuXin Zhang MD, Henghui Wu MD, Guangzhi Liu PhD   +8 more
doaj   +1 more source

Losing a Mother Battling Cancer: Perspectives of an Academic Psychiatric Nurse

Journal of Psychiatric and Mental Health Nursing, Volume 32, Issue 5, Page 1091-1096, October 2025.
ABSTRACT Purpose This paper aimed to share the subjective experiences of an academic psychiatric nurse who lost her mother to terminal cancer and to reveal the impact of this loss on her professional identity and nursing practices. Background The terminal cancer process affects not only patients but also their family members emotionally.
Merve Uğuryol Ünal
wiley   +1 more source

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy

BMC Pharmacology and Toxicology, 2023
Background Albumin-bound paclitaxel (nab-paclitaxel), as a special targeted preparation of paclitaxel, has the advantages of good curative effect and less side effects in anti-tumor therapy. The existence of the plasma-peritoneal barrier and insufficient
Jingjing Zhang, Luya Li, Jintuo Yin, Xidong Zhang, Ying Zheng, Rui Feng   +5 more
doaj   +1 more source

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review [PDF]

, 2022
Antonio Sommariva, Mario Valle, Roberta Gelmini, Marco Tonello, Fabio Carboni, Giovanni De Manzoni, Lorena Sorrentino, Enrico Maria Pasqual, Stefano Bacchetti, C. Sassaroli, Andrea Di Giorgio, Massimo Framarini, Daniele Marrelli, Francesco Casella, Orietta Federici   +14 more
openalex   +1 more source

Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis [PDF]

, 2015
Background Peritoneal carcinomatosis occurs in different cancer subtypes and is associated with a dismal prognosis. Some doubts remain whether the whole abdomen can be treated by regional hyperthermia, therefore we analyzed feasibility conducting a pilot
Beck, Marcus, Budach, Volker, Burock, Susen, Ghadjar, Pirus, Nadobny, Jacek, Sehouli, Jalid, Weihrauch, Mirko, Wust, Peter   +7 more
core   +2 more sources

Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.

Current Oncology, 2020
Objective The purpose of the present review was to provide evidence-based guidance about the provision of cytoreductive surgery (crs) with hyperthermic intraperitoneal chemotherapy (hipec) in the treatment of peritoneal cancers.
R. Auer, D. Sivajohanathan, J. Biagi, J. Conner, E. Kennedy, T. May   +5 more
semanticscholar   +1 more source

Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study

Cancer Medicine, Volume 14, Issue 18, September 2025.
ABSTRACT Background Cross‐resistance is observed between platinum and Poly (ADP‐ribose) polymerase inhibitors (PARPi). We aim to propose the definition of PARPi resistance and demonstrate the best therapeutic strategy for patients with PARPi resistance.
Rui Gou, Qi Xie, Haishan Ren, Hui Zhang, Tingting Wang, Ziyu Li, Zhenning Li, Ruichen Wang, Yingchao Yang, Xiaoyan Shen, Yi Li, Yue Wang, Lihui Wei, Xiaoping Li   +13 more
wiley   +1 more source

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients

Haseki Tıp Bülteni, 2019
Aim:Hyperthermic intraperitoneal chemotherapy with cytoreductive surgery has a positive effect on survival in advanced abdominal cancers. We aimed to present our experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ...
Özgül Düzgün, Sema Yüksekdağ, Murat Kalın, Şenol Çomoğlu, Semra Yanık, Ömer Faruk Özkan, Neşet Köksal   +6 more
doaj   +1 more source

Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC [PDF]

, 2018
Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric ...
Brandl, Andreas, Feist, Mathilde, Katou, Shadi, Pratschke, Johann, Rau, Beate, Raue, Wieland   +5 more
core   +1 more source